$ETRM, Most Active Volume Stock: EnteroMedics I
Post# of 22755
Most Active Volume Stock: EnteroMedics Inc. (NASDAQ:ETRM)
By
Mindy Sparks -
December 9, 2016
EnteroMedics Inc. (NASDAQ:ETRM) belonging to the Medical sector has surged 29.07% and closed its last trading session at $0.07.
The company reported its EPS on 11/07/2016. Currently, the stock has a 1 Year Price Target of $1.1.
The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 2 respectively.
EnteroMedics Inc. on 11/07/2016 reported its EPS as $-0.17 with the analysts projecting the EPS of the stock as $-0.5. The company beat the analyst EPS Estimate with the difference of $0.33. This shows a surprise factor of 66%.
Many analysts have provided their estimated foresights on EnteroMedics Inc. Earnings, with 1 analysts believing the company would generate an Average Estimate of $-0.5. Whereas they predicted High and Low Earnings Estimate as $-0.5 and $-0.5 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.95.
Analysts are also projecting an Average Revenue Estimate for EnteroMedics Inc. as $300 Million in the Current Quarter. This estimate is provided by 1 analysts. The High Revenue estimate is predicted as 300 Million, while the Low Revenue Estimate prediction stands at 300 Million. The company’s last year sales total was 149 Million.
The Company got Downgrade by ROTH Capital on 9-Jun-16 from Buy to Neutral.
Insider Trades for EnteroMedics Inc. show that the latest trade was made on 2 Jun 2016 where Delange (Peter M), the Officer completed a transaction type “Buy” in which 20000 shares were traded at a price of $0.55.
1 analysts projected Price Targets for EnteroMedics Inc.. The analysts believe that the company stock price could grow as high as $2. The Low Price target projection by analysts is $2 and the Mean Price Target is $2.
EnteroMedics Inc. (NASDAQ:ETRM) has the market capitalization of $7.82 Million. The company rocked its 52-Week High of $2.7 on Dec 31, 2015 and touched its 52-Week Low of $0.04 on Nov 22, 2016. The stock has Return on Assets (ROA) of -197.6 percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) of -568.7 percent.
The stock is currently showing YTD performance of -96.43 Percent. The company has Beta Value of 2.16 and ATR value of 0.02. The Weekly and Monthly Volatility stands at 22.31% and 29.56%.
Company profile:
EnteroMedics Inc. was established to develop and commercialize a new therapeutic platform for treating a wide range of acute and chronic diseases that are mediated by the vagal nerves. Due to the large unmet need for more effective surgical management of obesity, and following an in-depth analysis of how the vagus nerve affects food intake and processing, EnteroMedics has selected obesity management as its primary focus.
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'